Why Caplin Point shares fell 7.20% today, 18 November 2026
Caplin Point Laboratories fell 7.20% on 18 November 2026 despite 17.9% revenue growth in its September quarter, while the Nifty Midcap 100 lost 1.22%.
A 7.20% fall in a market that lost far less
Caplin Point Laboratories closed at ₹2,346.80 on 18 November 2026, down 7.20% on the day. That is a sharp fall by any standard, and it stands out against the wider tape.
The Nifty 50 slipped 0.63% to 25,227.95. The BSE Sensex gave up 0.61% and ended at 82,031.81. Nifty Bank was off 0.38% at 62,038.65. So the market was soft, but nothing like the hit this one share took.
India VIX stayed at 15.52, unchanged on the day. Nothing in that reading suggests a market in a panic. The pressure on Caplin Point looks specific to the stock rather than a general rush for the exits.
Growth in the books, a drop on the screen
The latest reported quarter does not read like a weak one. Revenue rose 17.9% on the year and profit climbed 15.3%. Profit growing a little slower than sales is common enough, and here the gap is modest.
The share trades at a P/E of 24.8 on those numbers. That is simply where the price stands after the fall, and it sits alongside a business that grew at a healthy clip over the year.
Those results were filed with the Exchange on 12 November 2026, covering the period ended 30 September 2026. That was six days before today's fall. The filing itself is a routine submission of financial results, and it carries no stated value for any payout or order.
No filing or announcement explains today's drop. There is no fresh news item on the company either. The only company document in the days just before the fall is the results submission, and the growth numbers in it do not point to a setback.
Healthcare barely moved while Caplin Point slid
Healthcare was one of the steadier corners of the market. The sector averaged a fall of 0.17% across 44 stocks, and 21 of them ended higher. That is close to an even split between gainers and losers.
Against that, a 7.20% fall is not a sector story. If the whole pharmaceutical space had been sold off, the sector average would have shown it. It did not.
The worst hit areas were elsewhere. Metals and Mining lost 2.30%, with only 2 of 20 stocks rising. Consumer Durables fell 1.76%, and Services dropped 1.74%, with none of its 14 stocks ending higher. Media, Entertainment and Publication was the best performer, up 1.47% across four stocks.
Oil, Gas and Consumable Fuels was a shade weaker at 0.28% lower, with 8 of 19 stocks up. Healthcare sat comfortably in the middle of this ranking.
Where the price now sits in its year
At ₹2,346.80, the share is well below its 52-week high of ₹2,990. It is also far above the 52-week low of ₹1,495.03. So today's close lands in the upper half of the year's range, but not near the top.
Over the past month the share had gained 0.37%. That is nearly flat. In other words, the stock was going nowhere in particular until today's fall, which then did most of the work in a single session.
The Nifty Midcap 100 lost 1.22% on the day, a heavier fall than the large-cap indices. Mid-sized companies had a harder day than the big ones, and that may have added some weight. Even so, the midcap fall is a sixth of what Caplin Point suffered.
What the Moon showed over the company's chart
On the jyotish side, the day looked friendly on paper. Shatabhisha held the Moon, and from the birth star Mula that is Sadhana tara, the star of achievement. The transit Moon stood in the 3rd house from the natal Moon, one of the six houses where it gives good results.
The Moon also crossed the natal Shukra, a natural benefic. The market opened under Dhanu lagna, the 1st sign from the company's Moon. The company's own ashtakavarga gave the Moon 4 bindus in Kumbha, which is a neutral reading.
Since 2016, shares under these readings beat the median share on between 49.74% and 49.95% of 2,684 days. The share fell all the same.
Why did Caplin Point Laboratories shares fall today?
The share closed 7.20% lower on 18 November 2026. No filing or announcement explains the fall, and the latest quarter showed revenue up 17.9% and profit up 15.3%.
What were Caplin Point's latest results?
For the quarter ended 30 September 2026, revenue rose 17.9% and profit rose 15.3% on the year. The results were submitted to the Exchange on 12 November 2026.
How did the healthcare sector and the market do today?
Healthcare averaged a fall of 0.17%, with 21 of 44 stocks higher. The Nifty 50 lost 0.63% and the Nifty Midcap 100 lost 1.22%.